Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Alexia Howard

Bernstein · covers Consumer Defensive

Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q3 (9 quarters).

Questions
69on tracked calls
Challenge rate
9%6 of 69 questions
Companies
8questioned at least once
Reporting periods
9with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 69 of 69 questions from 8 companies

MKCMcCormick & Company16 questions · 8 reporting periods · 2 of 16 challenging
MKC company page →

Calendar 2026 Q3

You talked about portfolio assortment optimization to better serve distinct consumer needs.

Product LaunchCompetitive DynamicsTranscript · FY2026 Q3 →
Show response

Foley cited prioritizing top-selling flavors, price pack architecture and innovation replacing slow items, while total distribution is still growing.

should we expect pricing to turn negative in U.S. Consumer as it did a couple of years ago

Show response

Foley ruled out negative pricing but said the pricing contribution will likely be smaller than year-to-date.

Calendar 2026 Q2

can you be more specific about which food service channels are seeing that recovery?

Show response

Foley named QSRs (Americas), fast casual, and non-commercial as the channels driving branded food service traffic growth.

21% at close is already fairly high relative to other food companies around the world.

ChallengingMarginM&ATranscript · FY2026 Q2 →
Show response

Foley and Gabriel said the combined margin profile is not built on an unusually low SG&A base, but deferred detail to the integration process.

Calendar 2026 Q1

Are you able to put a number or an order of magnitude around that?

Show response

Marcos declined to quantify specific year-one accretion but confirmed it is meaningfully accretive across all P&L lines including EPS. Said combined operating margin expected to reach 23-25% with $600M synergies. More specific numbers to come closer to close.

where do you see the revenue synergies being most significant?

M&AGeographic ExpansionTranscript · FY2026 Q1 →
Show response

Brendan said revenue synergies span all regions: Asia Pacific markets where Unilever operates but McCormick doesn't, EMEA expansion, North America portfolio strengthening, and Latin America southern cone via Unilever's Brazil presence. Fernando highlighted food service and brand range expansion opportunities.

Calendar 2025 Q4

I think we're now on year five where the earnings expectations are below your long-term algorithm

ChallengingGuidance ReliabilityMarginTranscript · FY2025 Q4 →
Show response

Brendan expressed confidence in hitting Investor Day top-line targets by 2028 but acknowledged need to work through substantial incremental costs from 2025-2026. Plans to provide more color on adjusted pathways at CAGNY. Did not commit on bottom-line algorithm timing.

Is that expected to sort of pick up through the course of 2026?

Innovation & R&DRevenue GrowthTranscript · FY2025 Q4 →
Show response

Brendan said development activity will continue to pick up in FY2026, but commercialization is more delayed, late 2026 at earliest for large CPG projects, more meaningfully in 2027. Emerging brands move to shelf faster.

Calendar 2025 Q3

Walmart announced last week that I think across the whole of their private label business, they're planning to eliminate 30 additives

Innovation & R&DCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Brendan said growth coming from high-growth innovators, emerging brands, and private label customers with accelerated growth. Reformulation activity consistent with Q2 comments: focus on natural colors from synthetic, reduced sugar/salt, eliminating ingredients of concern.

Could you talk about maybe just in broad terms what your acquisition strategy is and the magnitude of the types of deals

M&ACapital AllocationTranscript · FY2025 Q3 →
Show response

Brendan declined to comment on speculation about specific targets. Said consumer focus is herbs/spices/seasonings and condiments/sauces globally. Flavor solutions focus is technology and taste competencies. Currently focused on closing McCormick de Mexico in early 2026.

Calendar 2025 Q2

Is that going to be a meaningful step-up in investment? Or is it a similar level of investment next year as maybe you've seen this year?

Capex InvestmentInnovation & R&DTranscript · FY2025 Q2 →
Show response

Brendan said ERP pivoted to functional deployment approach to derisk. Spend normalized and will be in line with current year. Broader digital/AI investment will continue separately.

what do you make of the expanded list of over 40 additives that Texas is planning to require unpack labels

Regulation PolicyInnovation & R&DTranscript · FY2025 Q2 →
Show response

Brendan advocated for national-level regulation over state-by-state approach. Said it's too early to address specific impacts of a 40-item additive list. Working with Consumer Brands Association on the issue.

Calendar 2025 Q1

RFK Jr. seems to be pursuing an agenda of driving out artificial additives across packaged food and probably in the restaurant sector as well

Regulation PolicyInnovation & R&DTranscript · FY2025 Q1 →
Show response

Brendan confirmed reformulation activity is increasing beyond just colors, sodium reduction, clean ingredients, hydration, functional foods, high protein. McCormick portfolio has very little artificial color usage.

can I focus on the growth of sales in Flavor Solutions. I'm wondering if you could quantify or at least comment on how much new high -- these new high-growth customers are adding

DemandCompetitive DynamicsTranscript · FY2025 Q1 →
Show response

Brendan declined to quantify individual segment contributions but described strong growth from emerging health/wellness customers plus QSR innovation wins in Americas and Asia Pacific, offsetting CPG softness.

Calendar 2024 Q4

If we see a number of food additives like Red No. 3 or some of the others eliminated from the generally recognized as safe designation

Regulation PolicyInnovation & R&DTranscript · FY2024 Q4 →
Show response

Brendan expressed confidence in participating in reformulation trends, citing existing work on removing artificial colors, sodium reduction, and clean ingredients.

can I ask about the pivot that you're doing in the Flavor Solutions segment into these new faster growth innovative customers? I know you started that maybe a year or two ago

Competitive DynamicsInnovation & R&DTranscript · FY2024 Q4 →
Show response

Brendan described growth categories but declined to share portfolio composition breakdown. Cited strength in Branded Foodservice and gaining share overall.

HSYHershey Company (The)12 questions · 7 reporting periods · 1 of 12 challenging
HSY company page →

Calendar 2026 Q2

Would you expect a fairly rapid improvement in the volume trends as we move into the back half

DemandRevenue GrowthTranscript · FY2026 Q2 →
Show response

Howard asked about the pace of volume recovery in NA confection; Kirk expects volume trends to improve as inflation eases, aided by Q4 Hershey brand activity. Direct.

Calendar 2026 Q1

at what point do you start to think about actually putting plant manufacturing capacity into that region

Geographic ExpansionCapex InvestmentTranscript · FY2026 Q1 →
Show response

Kirk outlined scale-then-insource progression for European manufacturing. U.K. playbook being replicated in Brazil and Mexico. Reese's platform exciting for international growth.

are you able to quantify where you're at in new products as a percent of sales introduced over, say, the last 3 years

Innovation & R&DProduct LaunchTranscript · FY2026 Q1 →
Show response

Kirk described high single-digit innovation contribution to sales. Focus areas: premium, sweets, better-for-you. Steve added incremental R&D investment being made.

Calendar 2025 Q4

Do you have views on why the trends seem to be worse in the international markets and why they're better over here at the moment

PricingGeographic ExpansionTranscript · FY2025 Q4 →
Show response

Kirk cited US category differentiation, mainstream affordability, and strong brand roles vs European high chocolate tablet/private label market. HSY international portfolio is premium-positioned with limited scale, driving higher elasticity.

Calendar 2025 Q3

Are you able to put any numbers around that in terms of percentage of sales from new products

Innovation & R&DProduct LaunchTranscript · FY2025 Q3 →
Show response

Kirk declined specific innovation % but emphasized REESE'S Oreo co-merchandising lifted core brands. Innovation critical for consumers but must build core alongside, balanced approach.

It seems as though you were having some trouble with that earlier in the year. It seemed to be in recovery

DemandCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Kirk noted CMG performing at +6 in convenience. Hyper focused on IC execution with gold standard planograms, innovation pipeline, and tentpole moments. Priority channel for brand building.

Calendar 2025 Q2

could you talk about the pace of innovation and how it stepped up over the last couple of years

Innovation & R&DProduct LaunchTranscript · FY2025 Q2 →
Show response

Michele noted innovation as percent of net sales up significantly vs 2019. Innovation needed for shelf space competition against insurgent brands and private label, and perceived as value by consumers.

How are you thinking about that as a potential impact next year? Obviously, the innovation, the marketing are obviously going to counter that

DemandRegulation PolicyTranscript · FY2025 Q2 →
Show response

Michele sees no material GLP-1 impact in 2025 or expected for 2026. SNAP rollout timing means no material impact until 2027+. Removing CMG from SNAP less concerning as consumers retain discretionary dollars.

Calendar 2025 Q1

When is that due to happen? And you mentioned that you expect it to be the biggest innovation ever on the brand

Product LaunchInnovation & R&DTranscript · FY2025 Q1 →
Show response

Michele confirmed fall timing but couldn't share details. Confidence from consumer demand signals and extensive research. Strong consumer pull identified.

Can you quantify what proportion of your overall sales still have additives in them that would be on the list

Regulation PolicyInnovation & R&DTranscript · FY2025 Q1 →
Show response

Michele identified sweets and coated chocolate products as most exposed. Ingredient costs are relatively small percentage. Natural coloring work already underway.

Calendar 2024 Q4

on the sales outlook for 2025, it's obviously fairly muted compared to the strong performance this time around. Is that mainly due to the conservative price elasticity

ChallengingRevenue GrowthPricingDemandTranscript · FY2024 Q4 →
Show response

Michele cited multiple factors: pressured international, retailer inventory dynamics, one fewer shipping day, and commercial activations weighted to back-half.

Are you seeing any material impact at the moment? How are you measuring it? And what's the strategy here as that plays out over time

DemandCompetitive DynamicsTranscript · FY2024 Q4 →
Show response

Michele cited multiple data sources including Cornell Enumerator studies showing GLP-1 users don't eat disproportionately less of their categories. Zero sugar and protein lines growing.

TSNTyson Foods12 questions · 6 reporting periods · 2 of 12 challenging
TSN company page →

Calendar 2026 Q2

freight cost inflation has come up as a problem for other companies. My understanding is that you’ve got a lot of owned freight

Cost PressureSupply ChainTranscript · FY2026 Q3 →
Show response

King confirmed fuel inflation since mid-April but said customer freight is a pass-through recovered with a one-to-two quarter lag, and the large internal fleet mitigates cost impacts.

what would it take to get beef profitability back to positive? Is that within reach at this point?

Cost PressureMarginTranscript · FY2026 Q3 →
Show response

Morris said beef is a top priority seven weeks into his role and past optimization delivered on plan but was offset by the live-to-cutout spread, without committing to a profitability timeline.

Calendar 2025 Q4

an update on HEPA retention and any signals that you're seeing out in the marketplace about how that's playing out

Show response

Devin cited USDA annual report: smallest herd since 1951, 9% below 2019; replacement heifers up 1% with regional variation; beef cow slaughter down 7% in 2025, below historical average; heifers on feed down 3.1% YoY; expects post-cycle herd to be smaller than historical numbers.

have you quantified how much the net savings are from the beef plant closure and the shift reduction

Cost PressureMarginTranscript · FY2026 Q1 →
Show response

Devin declined to provide specific savings figures; pointed to guidance as incorporating all quantifiable impacts; noted transition to new footprint just recently completed and intent to increase capacity utilization and continue operational improvements.

Calendar 2025 Q3

if you had to sort of prioritize the top 2 or 3 things that could go positively or negatively versus your forecast, what would those be

DemandCompetitive DynamicsTranscript · FY2025 Q4 →
Show response

Kristina Lambert addressed consumer divergence in incomes, protein demand continuation, chicken as preferred choice for value and convenience; cited 72% household penetration and growth with under-35 consumers; highlighted volume share gains across Tyson chicken, Hillshire lunch meat (+10%), and Hillshire Snacking (+12.5%).

Are you seeing any impact from the delay and disruption in the SNAP benefit payouts as a result of the government shutdown

Regulation PolicyDemandTranscript · FY2025 Q4 →
Show response

Kristina cited three reasons for resilience: diverse product portfolio at different budget levels, brand trust and loyalty (3 of top 10 brands in packaged protein), and market adaptability with real-time consumer behavior monitoring.

Calendar 2025 Q2

how significant the threat from New World screwworms is? I know that the border has been shut down with Mexico, but could this deter farmers from wanting to rebuild the herd

Supply ChainRegulation PolicyTranscript · FY2025 Q3 →
Show response

Brady quantified 500,000 fewer head imported from Mexico; stated no U.S. producer decisions to retain or cull based on screwworm threat; expressed confidence USDA actions will curtail further Northern movement.

If that is approved and it leads to increased corn prices, but fairly a decrease in soybean meal prices, on the chicken side of the business, are you able to significantly shift the mix of feed int...

Cost PressureRegulation PolicyTranscript · FY2025 Q3 →
Show response

Donnie explained corn-soybean meal ratio is fairly fixed for chicken feed formulation; noted grain prices look very steady with a potentially really high U.S. corn crop coming in, making substitution unlikely.

Calendar 2025 Q1

the guidance, you've obviously come through very strongly in the first half of the year, but keeping the guidance the same implies, I think, a fairly big decline year-over-year in operating income....

ChallengingGuidance ReliabilityMarginTranscript · FY2025 Q2 →
Show response

Donnie acknowledged uncertainty in back half; Devin Cole detailed reaffirmed guidance considers operating confidence, sustainable progress, back-half brand investments, diversified pricing models, and macro environment.

you beat consensus expectations this quarter on the profit line, but you didn't raise guidance for the full year. How did the result come through versus your internal expectations and what's coming...

ChallengingGuidance ReliabilityTranscript · FY2025 Q2 →
Show response

Donnie gave extensive overview of Q2 highlights before addressing guidance directly; Curt confirmed results came in line with internal expectations and guidance includes tariff and consumer dynamics assumptions.

Calendar 2024 Q4

could I just dig into the free cash flow coming down a little bit from last year? What was the driver of that

Capital AllocationCapex InvestmentTranscript · FY2025 Q1 →
Show response

Curt attributed FCF decline to working capital timing; noted CapEx range of $1-1.2B is the long-term average vs inflated $1.9B in FY22-23 from new facilities.

are you seeing any impact of the broader deportation activity that's recently begun on worker attendance or worker availability

Labor MarketRegulation PolicyTranscript · FY2025 Q1 →
Show response

Donnie detailed compliance measures including e-Verify, the IMAGE program, scenario planning for policy changes, and confirmed no ICE visits and no attendance changes.

SJMJ.M. Smucker Company (The)9 questions · 5 reporting periods · 0 of 9 challenging
SJM company page →

Calendar 2026 Q3

Would you expect this kind of momentum to continue out to the foreseeable future?

Revenue GrowthGeographic ExpansionTranscript · FY2027 Q1 →
Show response

Smucker sees ample runway via distribution expansion into Central/Western regions and new roast/RTD offerings.

Calendar 2026 Q1

the overall pace, the proportion of sales that are coming from new products, is that where you want it to be now

Innovation & R&DProduct LaunchTranscript · FY2026 Q3 →
Show response

Mark confirms innovation pace is where they want it. Closer-in innovation working well across Hostess, pet, Bustelo, and Uncrustables. Speed to market fastest ever.

you commented that you had lower marketing and distribution spending this quarter, but higher selling expenses. Is that a signal of a continuation of that kind of trend

Show response

Tucker clarifies: Q3 SG&A was timing/savings benefit locked into guidance but muted by Emporia fire top-line impact. Not a structural trend.

Calendar 2025 Q4

you're talking about getting it down to three times by 2027. How quickly does that start coming down

Capital AllocationTranscript · FY2026 Q2 →
Show response

Tucker provides clear deleveraging path: $500M paydown each in FY26 and FY27. Leverage stays ~4x through FY2026, then steps down toward 3x in FY2027.

Can I start with innovation and the pace of innovation? Are you able to quantify whether that's been accelerating

Innovation & R&DProduct LaunchTranscript · FY2026 Q2 →
Show response

Mark confirms accelerated innovation across Hostess, pet snacks, and Uncrustables. Speed to market is fastest ever. Seasonal flavors and protein innovations driving growth.

Calendar 2025 Q3

Was no mention of, potentially pursuing tariff exemptions in the mitigating activities that you're pursuing. Is there a chance

Trade TariffsRegulation PolicyTranscript · FY2026 Q1 →
Show response

Mark notes advocacy through industry associations but has nothing to report on relief. Would reflect any changes in guidance if relief materializes.

are you seeing any impact from, GLP-one drugs specifically? And should we be concerned that with pill versions coming out early in calendar '26

DemandMacroeconomicTranscript · FY2026 Q1 →
Show response

Mark maintains monthly monitoring shows no meaningful GLP-1 impact. Portfolio well-positioned with portion size and reduced sugar options.

Calendar 2024 Q4

how are you tackling the question of gathering information about what the consumer needs there? You've obviously got some parts of the portfolio that play well into that segment

DemandMacroeconomicTranscript · FY2025 Q2 →
Show response

Mark highlights portfolio breadth (pet, coffee, spreads). Ongoing GLP-1 research shows no material impact to date. Positions it as opportunity for innovation.

On Wortmann, the divestment, you've said that you expected a ten cents hit to earnings this year. Is that based on the expectation that it will close at the end of the third quarter

M&ACapital AllocationTranscript · FY2025 Q2 →
Show response

Tucker confirms full-year Wortmann impact of $0.25, $0.10 in FY2025, partially offset by $300M debt paydown leaving ~$0.05 net impact.

CAGConagra Brands8 questions · 5 reporting periods · 0 of 8 challenging
CAG company page →

Calendar 2026 Q3

the 3x being the long-term target, and I think it increased a little bit this quarter to close to 4x.

Capital AllocationCreditTranscript · FY2027 Q1 →
Show response

Howard asked about the deleveraging timeline toward 3x; Marberger pointed to a favorable 3.99x Q1 finish and about $250 million of planned FY debt paydown.

Calendar 2026 Q2

what sort of price elasticity assumption are you making in terms of the impact on volumes

Show response

Neisius pointed to volumes down mid single digits and a price/mix of roughly plus 3%, with frozen elasticities set higher than historical and grocery/snacks nearer 1-to-1.

Calendar 2025 Q4

are there any numbers you can put around where you're at? And I assume that you're now significantly above where you were a few years ago during COVID.

Innovation & R&DProduct LaunchDemandTranscript · FY2026 Q2 →
Show response

Sean noted TPDs secured and velocity per TPD improving year over year. Emphasized protein, clean label, and vegetable nutrition as key innovation pillars. Highlighted young consumer over-indexing with health-focused brands like Healthy Choice and Birds Eye.

Now that we've shifted to much colder weather across the US, just seeing if there's any color commentary around, quarter-to-date trends.

Show response

Sean explained two weather headwinds: no hurricane activity (versus unusually high prior year) and delayed cold weather onset for seasonal canned food. Cold weather now arrived and driving expected seasonal demand for cocoa, tomatoes, and chili.

Calendar 2025 Q1

there seems to be a lot of activity at the state level to introduce bans or labeling requirements on certain additives

Regulation PolicyCost PressureTranscript · FY2025 Q3 →
Show response

Sean noted minimal exposure given 90%+ of portfolio is free of synthetic dyes. State-by-state regulation is harder to manage than federal but not material for Conagra.

can you comment on any recent changes in the state of the consumer and behaviors that are shifting

DemandMacroeconomicTranscript · FY2025 Q3 →
Show response

Sean characterized it as continuation of existing value-seeking behavior rather than new deterioration. Conagra well-positioned with frozen convenience and protein snacking.

Calendar 2024 Q3

is the category growth being affected by some of that pullback, particularly in light of the fairly significant pullback that you saw this quarter

Competitive DynamicsInnovation & R&DTranscript · FY2025 Q1 →
Show response

Sean argued brand-building investment is in COGS (innovation/packaging) rather than A&P line, and digital/social focus has replaced low-ROI traditional TV.

just about where price/mix goes from here now that we're lapping the tomato product price increase

PricingRevenue GrowthTranscript · FY2025 Q1 →
Show response

Dave indicated price/mix will remain negative for the full year but the rate of decline should moderate going forward.

GISGeneral Mills7 questions · 4 reporting periods · 1 of 7 challenging
GIS company page →

Calendar 2026 Q3

Where are we at with leverage at the moment? I know that your goal is to bring it down to 3x net debt to EBITDA.

Capital AllocationTranscript · FY2027 Q1 →
Show response

Kofi said returning to the 3x net debt/EBITDA target will take at least a couple of years and confirmed leverage now sits just over 4.

You said that the marketing spend was up significantly this quarter. How much is it up year-on-year?

MarginCapital AllocationTranscript · FY2027 Q1 →
Show response

Dana clarified media was up only modestly in Q1 and should be up low single digits for the year, with the bigger story being modernized, faster content and influencer marketing.

Calendar 2026 Q1

Is there another milestone in terms of additional distribution that you can share

Show response

CEO said focus is on improving turns through better on-shelf availability, lower-funnel marketing, and adding stand-up resealable pouch SKUs to existing stores rather than adding more store locations.

You mentioned bakery flour volumes. Is that something that is likely to persist?

DemandCompetitive DynamicsTranscript · FY2026 Q3 →
Show response

CEO attributed Foodservice profit decline roughly half to yogurt divestiture and 30-35% to flour; expects flour recovery in Q4 and highlighted strong K-12 competitiveness with natural colors transition completed ahead of schedule.

Calendar 2025 Q3

are you able to say what percentage of sales are now coming from new products introduced over the last year

Innovation & R&DRevenue GrowthTranscript · FY2026 Q1 →
Show response

CEO highlighted innovation contribution rising from 3.5% to 5% of net sales, with emphasis on bigger, more on-trend ideas across all segments including international.

are the ingredient list and additives coming up as concerns for some group of consumers?

Regulation PolicyInnovation & R&DTranscript · FY2026 Q1 →
Show response

CEO noted 98% of K-12 and 85% of retail already free of certified colors; advocated for federal regulation over state-by-state approach to reduce cost and consumer confusion.

Calendar 2025 Q1

could this accelerated uptake of GLP-1 drugs, for example, or increasing consumer concerns about the healthiness of indulgent snacks, be another part of the issue

ChallengingDemandMacroeconomicTranscript · FY2025 Q3 →
Show response

CEO dismissed GLP-1 as primary driver, attributing snack weakness to elevated food-at-home consumption at 87% vs 83% pre-pandemic and consumer value-seeking.

Show 2 more companies
KHCKraft Heinz3 questions · 3 reporting periods · 0 of 3 challenging
KHC company page →

Calendar 2025 Q2

Can you talk about where you're at today as a percentage of sales? Where you'd like to get to over time and how quickly you could get there

Innovation & R&DProduct LaunchTranscript · FY2025 Q2 →
Show response

CEO quantified innovation from 1.6% of sales in 2022 to 3% by end of 2024. Cited Taco Bell at-home growing double digits in second year, Capri Sun bottle achieving high velocities in new channels, and Heinz pasta sauce and Mayo expanding internationally.

Calendar 2025 Q1

Should we be thinking about that from a top line perspective, or is that related to cost

Guidance ReliabilityTrade TariffsTranscript · FY2025 Q1 →
Show response

CEO provided a vague answer, citing multiple scenarios without specifying whether policy impacts were top-line or cost-driven, maintaining wide guidance range for flexibility.

Calendar 2024 Q4

do you believe Kraft Heinz is seeing any impact from them? And what opportunities are there to meet the unmet needs of these patients

DemandInnovation & R&DTranscript · FY2024 Q4 →
Show response

CEO said no meaningful GLP-1 impact, highlighted protein-rich portfolio including Oscar Mayer, Lunchables, P3, and Taste Elevation platform as positioning for protein demand trend.

MDLZMondelez International2 questions · 1 reporting period · 0 of 2 challenging
MDLZ company page →

Calendar 2025 Q2

It seems as though you are taking on a bit more debt in order to repurchase shares

Capital AllocationTranscript · FY2025 Q2 →
Show response

Luca said debt increase mainly FX-driven on diversified currency debt plus net investment hedges. Pragmatic approach to buybacks at compelling prices. Believes this will be one of best capital deployment decisions.

How are you thinking about the GLP-1 impact on these indulgent snacking categories

DemandMacroeconomicTranscript · FY2025 Q2 →
Show response

Dirk presented data: 4% penetration, 11% calorie reduction, 9-month average duration. Net effect is 0.4% of total calorie intake, virtually invisible. Penetration not increasing. Even 10-year extrapolation shows insignificant impact.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
MKC McCormick & Company1613%2 of 16 questions
HSY Hershey Company (The)128%1 of 12 questions
TSN Tyson Foods1217%2 of 12 questions
SJM J.M. Smucker Company (The)90%none of 9 questions
CAG Conagra Brands80%none of 8 questions
GIS General Mills714%1 of 7 questions
KHC Kraft Heinz30%none of 3 questions
MDLZ Mondelez International2—Rate withheld: fewer than 3 questions
  • MKC
    McCormick & Company · 16 questions
    13%2 of 16 questions
  • HSY
    Hershey Company (The) · 12 questions
    8%1 of 12 questions
  • TSN
    Tyson Foods · 12 questions
    17%2 of 12 questions
  • SJM
    J.M. Smucker Company (The) · 9 questions
    0%none of 9 questions
  • CAG
    Conagra Brands · 8 questions
    0%none of 8 questions
  • GIS
    General Mills · 7 questions
    14%1 of 7 questions
  • KHC
    Kraft Heinz · 3 questions
    0%none of 3 questions
  • MDLZ
    Mondelez International · 2 questions
    —rate withheld: under 3 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2024 Q320%none of 2 questions1
2024 Q4911%1 of 9 questions5
2025 Q11030%3 of 10 questions6
2025 Q290%none of 9 questions5
2025 Q3100%none of 10 questions5
2025 Q4911%1 of 9 questions5
2026 Q180%none of 8 questions4
2026 Q2617%1 of 6 questions4
2026 Q360%none of 6 questions4
  1. 2024 Q32 questions · challenge rate 0% (none of 2 questions) · 1 company
  2. 2024 Q49 questions · challenge rate 11% (1 of 9 questions) · 5 companies
  3. 2025 Q110 questions · challenge rate 30% (3 of 10 questions) · 6 companies
  4. 2025 Q29 questions · challenge rate 0% (none of 9 questions) · 5 companies
  5. 2025 Q310 questions · challenge rate 0% (none of 10 questions) · 5 companies
  6. 2025 Q49 questions · challenge rate 11% (1 of 9 questions) · 5 companies
  7. 2026 Q18 questions · challenge rate 0% (none of 8 questions) · 4 companies
  8. 2026 Q26 questions · challenge rate 17% (1 of 6 questions) · 4 companies
  9. 2026 Q36 questions · challenge rate 0% (none of 6 questions) · 4 companies

Topics

Topics tagged on this analyst’s questions.

  • Innovation & R&D20
  • Demand19
  • Regulation Policy12
  • Product Launch10
  • Competitive Dynamics9
  • Capital Allocation8
  • Margin8
  • Revenue Growth6
  • Pricing5
  • Cost Pressure5
Show all 19 topics
  • M&A5
  • Macroeconomic5
  • Geographic Expansion4
  • Guidance Reliability4
  • Supply Chain3
  • Capex Investment3
  • Trade Tariffs2
  • Credit1
  • Labor Market1